search

Active clinical trials for "Depressive Disorder"

Results 1681-1690 of 5015

Transcranial Magnetic Stimulation (rTMS) Accelerates the Response to Escitalopram in Major Depression...

Major Depression

A doubleblind randomised trial with active versus sham rTMS in combination with escitalopram in patients with prior treatment resistant depression in an acute 12 weeks trial with subsequent 24 weeks study phase with active versus placebo citalopram

Completed6 enrollment criteria

Lethargic Depression Study

EpilepsyMajor Depressive Disorder (MDD)

This is a study of Major Depressive Disorder (MDD) in patients with decreased energy, pleasure and interests.

Completed7 enrollment criteria

Outreach and Treatment for Depression in the Labor Force

Depression

This study will assess the effects of depression treatment on employee productivity. This study will also evaluate the impact of depression screening and outreach on employees' receptivity to treatment.

Completed2 enrollment criteria

Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana...

Depressive DisorderMajor1 more

Adolescents who are diagnosed with major depressive disorder are often also diagnosed with marijuana dependence. Fluoxetine is an antidepressant medication currently used to treat young people who are diagnosed with major depressive disorder. The purpose of this study is to determine the effectiveness of fluoxetine in treating adolescents and young adults diagnosed with both major depressive disorder and marijuana dependence.

Completed14 enrollment criteria

Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder

Major Depressive Disorder

The purpose of this clinical research study is to learn whether BMS-562086 is both safe and effective in treating outpatients with major depressive disorder.

Completed4 enrollment criteria

Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1

DepressionMarijuana Abuse

The purpose of this study is to determine if Venlafaxine Extended Release (Ven-XR) is effective in treating individuals with marijuana addiction and depression.

Completed14 enrollment criteria

Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors

Cardiovascular DiseasesDepression4 more

This study will determine the effects of omega-3 fatty acid (FA) augmentation of sertraline on depression and cardiac endpoints after myocardial infarction (MI).

Completed17 enrollment criteria

Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder

Depressive DisorderMajor

The purpose of this study is to assess the efficacy and safety of duloxetine compared with placebo in the prevention of depressive recurrences among patients with recurrent major depressive disorder.

Completed8 enrollment criteria

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

This trial is a 14 week, randomized, double-blind, placebo controlled study, to assess the safety and efficacy of aripiprazole as adjunctive treatment to an ongoing antidepressant treatment in patients with Major Depressive Disorder.

Completed3 enrollment criteria

Major Depressive Disorder In The Elderly

Depressive DisorderMajor

This is a placebo-controlled study evaluating the effectiveness of medication in elderly subjects with Major Depressive Disorder (MDD).

Completed5 enrollment criteria
1...168169170...502

Need Help? Contact our team!


We'll reach out to this number within 24 hrs